{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:23:01Z","timestamp":1791156181876,"version":"4.1.0"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1093\/jnci\/dju215","type":"journal-article","created":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T00:26:20Z","timestamp":1407371180000},"source":"Crossref","is-referenced-by-count":83,"title":["mTOR Co-Targeting in Cetuximab Resistance in Head and Neck Cancers Harboring PIK3CA and RAS Mutations"],"prefix":"10.1093","volume":"106","author":[{"given":"Zhiyong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo A.","family":"Molinolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vyomesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"Iglesias-Bartolome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sol Degese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Vitale-Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Silvio","family":"Gutkind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,8,5]]},"reference":[{"issue":"15","key":"key\n\t\t\t\t20170521015742_CIT0001","first-page":"3579","article-title":"Elevated Levels of Transforming Growth Factor a and Epidermal Growth Factor Receptor Messenger RNA Are Early Markers of Carcinogenesis in Head and Neck Cancer","volume":"53","author":"Grandis","year":"1993","journal-title":"Cancer Res"},{"issue":"17","key":"key\n\t\t\t\t20170521015742_CIT0002","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1200\/JCO.2005.04.8306","article-title":"Epidermal growth factor receptor biology in head and neck cancer","volume":"24","author":"Kalyankrishna","year":"2006","journal-title":"J Clin Oncol"},{"issue":"11","key":"key\n\t\t\t\t20170521015742_CIT0003","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/jnci\/90.11.824","article-title":"Levels of TGF-alfa and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival","volume":"90","author":"Grandis","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"25","key":"key\n\t\t\t\t20170521015742_CIT0004","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1200\/JCO.2006.07.2587","article-title":"Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas","volume":"24","author":"Chung","year":"2006","journal-title":"J Clin Oncol"},{"issue":"4","key":"key\n\t\t\t\t20170521015742_CIT0005","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/sj.onc.1201188","article-title":"Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells","volume":"15","author":"Grandis","year":"1997","journal-title":"Oncogene"},{"issue":"13","key":"key\n\t\t\t\t20170521015742_CIT0006","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1158\/1078-0432.CCR-05-2404","article-title":"Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells","volume":"12","author":"Erjala","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"10","key":"key\n\t\t\t\t20170521015742_CIT0007","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1349-7006.2006.00287.x","article-title":"Small interfering RNA targeting epidermal growth factor receptor enhances chemosensitivity to cisplatin, 5-fluorouracil and docetaxel in head and neck squamous cell carcinoma","volume":"97","author":"Nozawa","year":"2006","journal-title":"Cancer Sci"},{"issue":"6","key":"key\n\t\t\t\t20170521015742_CIT0008","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1517\/13543781003769844","article-title":"Investigational EGFR-targeted therapy in head and neck squamous cell carcinoma","volume":"19","author":"Cassell","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"issue":"6","key":"key\n\t\t\t\t20170521015742_CIT0009","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"issue":"11","key":"key\n\t\t\t\t20170521015742_CIT0010","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer","volume":"359","author":"Vormorken","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"key\n\t\t\t\t20170521015742_CIT0011","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nm.2609","article-title":"Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer","volume":"18","author":"Montagut","year":"2012","journal-title":"Nat Med"},{"issue":"99","key":"key\n\t\t\t\t20170521015742_CIT0012","doi-asserted-by":"crossref","first-page":"99ra86","DOI":"10.1126\/scitranslmed.3002442","article-title":"Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab","volume":"3","author":"Yonesaka","year":"2011","journal-title":"Sci Transl Med"},{"issue":"17","key":"key\n\t\t\t\t20170521015742_CIT0013","doi-asserted-by":"crossref","first-page":"8240","DOI":"10.1158\/0008-5472.CAN-07-0589","article-title":"Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance escaping treatment by the anti-EGFR monoclonal antibody cetuximab","volume":"67","author":"Lu","year":"2007","journal-title":"Cancer Res"},{"issue":"5","key":"key\n\t\t\t\t20170521015742_CIT0014","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1158\/1078-0432.CCR-08-2068","article-title":"Establishment and characterization of a model of acquired resistance to epidermal growth factor receptor targeting agents in human cancer cells","volume":"15","author":"Benavente","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"43","key":"key\n\t\t\t\t20170521015742_CIT0015","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1038\/onc.2009.234","article-title":"Nuclear EGFR contributes to acquired resistance to cetuximab","volume":"28","author":"Li","year":"2009","journal-title":"Oncogene"},{"issue":"28","key":"key\n\t\t\t\t20170521015742_CIT0016","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1038\/onc.2008.19","article-title":"Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members","volume":"27","author":"Wheeler","year":"2008","journal-title":"Oncogene"},{"issue":"9","key":"key\n\t\t\t\t20170521015742_CIT0017","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrclinonc.2010.97","article-title":"Understanding resistance to EGFR inhibitors-impact on future treatment strategies","volume":"7","author":"Wheeler","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"key\n\t\t\t\t20170521015742_CIT0018","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrc2088","article-title":"Epidermal growth factor receptor mutations in lung cancer","volume":"7","author":"Sharma","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"key\n\t\t\t\t20170521015742_CIT0019","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrc3559","article-title":"Targeting the ERBB family in cancer: couples therapy","volume":"13","author":"Tebbutt","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"key\n\t\t\t\t20170521015742_CIT0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1359-6101(01)00029-6","article-title":"Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition","volume":"13","author":"Maulik","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"issue":"21","key":"key\n\t\t\t\t20170521015742_CIT0021","doi-asserted-by":"crossref","first-page":"9953","DOI":"10.1158\/0008-5472.CAN-05-0921","article-title":"Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck","volume":"65","author":"Amornphimoltham","year":"2005","journal-title":"Cancer Res"},{"issue":"17","key":"key\n\t\t\t\t20170521015742_CIT0022","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1158\/1078-0432.CCR-07-1041","article-title":"Dissecting the Akt\/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative","volume":"13","author":"Molinolo","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"9","key":"key\n\t\t\t\t20170521015742_CIT0023","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1158\/1078-0432.CCR-11-2824","article-title":"mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas","volume":"18","author":"Molinolo","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"7","key":"key\n\t\t\t\t20170521015742_CIT0024","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1158\/2159-8290.CD-13-0239","article-title":"Exploiting the head and neck cancer oncogenome: widespread PI3K-mTOR pathway alterations and novel molecular targets","volume":"3","author":"Iglesias-Bartolome","year":"2013","journal-title":"Cancer Discov"},{"issue":"4","key":"key\n\t\t\t\t20170521015742_CIT0025","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1158\/0008-5472.CAN-07-1756","article-title":"A retroinhibition approach reveals a tumor cell-autonomous response to rapamycin in head and neck cancer","volume":"68","author":"Amornphimoltham","year":"2008","journal-title":"Cancer Res"},{"issue":"1","key":"key\n\t\t\t\t20170521015742_CIT0026","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.molonc.2013.10.003","article-title":"A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis","volume":"8","author":"Leelahavanichkul","year":"2014","journal-title":"Mol Oncol"},{"key":"key\n\t\t\t\t20170521015742_CIT0027","author":"Massarelli","year":"2013"},{"issue":"6","key":"key\n\t\t\t\t20170521015742_CIT0028","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/lary.20917","article-title":"Teasing out the best molecular marker in the AKT\/mTOR pathway in head and neck squamous cell cancer patients","volume":"120","author":"Clark","year":"2010","journal-title":"Laryngoscope"},{"issue":"1","key":"key\n\t\t\t\t20170521015742_CIT0029","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11864-011-0180-2","article-title":"mTOR inhibitors and its role in the treatment of head and neck squamous cell carcinoma","volume":"13","author":"Nguyen","year":"2012","journal-title":"Curr Treat Options Oncol"},{"key":"key\n\t\t\t\t20170521015742_CIT0030","author":"Varadarajan","year":"2012"},{"issue":"1","key":"key\n\t\t\t\t20170521015742_CIT0031","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1517\/14728222.2011.541440","article-title":"EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy","volume":"15","author":"Freudlsperger","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"key\n\t\t\t\t20170521015742_CIT0032","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/1471-2407-13-320","article-title":"Anti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental models","volume":"13","author":"Ekshyyan","year":"2013","journal-title":"BMC Cancer"},{"issue":"7","key":"key\n\t\t\t\t20170521015742_CIT0033","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1158\/1078-0432.CCR-12-2426","article-title":"Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients","volume":"19","author":"Srivastava","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"1","key":"key\n\t\t\t\t20170521015742_CIT0034","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1158\/1940-6207.CAPR-08-0147","article-title":"Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model","volume":"2","author":"Czerninski","year":"2009","journal-title":"Cancer Prev Res (Phila)"},{"issue":"10","key":"key\n\t\t\t\t20170521015742_CIT0035","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1158\/0008-5472.CAN-08-4645","article-title":"Rapamycin prevents early onset of tumorigenesis in an oral-specific K-ras and p53 two-hit carcinogenesis model","volume":"69","author":"Raimondi","year":"2009","journal-title":"Cancer Res"},{"issue":"22","key":"key\n\t\t\t\t20170521015742_CIT0036","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1158\/0008-5472.CAN-10-3192","article-title":"Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer","volume":"71","author":"Patel","year":"2011","journal-title":"Cancer Res"},{"issue":"10","key":"key\n\t\t\t\t20170521015742_CIT0037","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.oraloncology.2011.07.013","article-title":"Mutational analysis of PTEN\/PIK3CA\/AKT pathway in oral squamous cell carcinoma","volume":"47","author":"Cohen","year":"2011","journal-title":"Oral Oncol"},{"issue":"5","key":"key\n\t\t\t\t20170521015742_CIT0038","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1158\/1078-0432.CCR-05-2173","article-title":"PIK3CA mutations in head and neck squamous cell carcinoma","volume":"12","author":"Qiu","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"7","key":"key\n\t\t\t\t20170521015742_CIT0039","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1158\/2159-8290.CD-13-0103","article-title":"Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers","volume":"3","author":"Lui","year":"2013","journal-title":"Cancer Discov"},{"issue":"12","key":"key\n\t\t\t\t20170521015742_CIT0040","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1349-7006.2006.00343.x","article-title":"PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma","volume":"97","author":"Kozaki","year":"2006","journal-title":"Cancer Sci"},{"issue":"7","key":"key\n\t\t\t\t20170521015742_CIT0041","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1158\/2159-8290.CD-12-0537","article-title":"Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers","volume":"3","author":"Pickering","year":"2013","journal-title":"Cancer Discov"},{"issue":"7","key":"key\n\t\t\t\t20170521015742_CIT0042","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/archotol.1994.01880310059011","article-title":"H-ras oncogene mutation and human papillomavirus infection in oral carcinomas","volume":"120","author":"Anderson","year":"1994","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"key\n\t\t\t\t20170521015742_CIT0043","doi-asserted-by":"crossref","DOI":"10.1002\/0471142905.hg1011s57","article-title":"The catalogue of somatic mutations in cancer (COSMIC)","author":"Forbes","year":"2008","journal-title":"Curr Protoc Hum Genet"},{"key":"key\n\t\t\t\t20170521015742_CIT0044","doi-asserted-by":"crossref","first-page":"848021","DOI":"10.1155\/2013\/848021","article-title":"Prevalence of K-RAS Codons 12 and 13 Mutations in Locally Advanced Head and Neck Squamous Cell Carcinoma and Impact on Clinical Outcomes","volume":"2013","author":"Bissada","year":"2013","journal-title":"Int J Otolaryngol"},{"issue":"1","key":"key\n\t\t\t\t20170521015742_CIT0045","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1368-8375(99)00058-5","article-title":"ras Gene mutations in oral cancer in eastern India","volume":"36","author":"Das","year":"2000","journal-title":"Oral Oncol"},{"issue":"16","key":"key\n\t\t\t\t20170521015742_CIT0046","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"Hay","year":"2004","journal-title":"Genes Dev"},{"issue":"2","key":"key\n\t\t\t\t20170521015742_CIT0047","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"issue":"3","key":"key\n\t\t\t\t20170521015742_CIT0048","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molonc.2012.11.001","article-title":"Molecular phenotype predicts sensitivity of squamous cell carcinoma of the head and neck to epidermal growth factor receptor inhibition","volume":"7","author":"Young","year":"2013","journal-title":"Mol Oncol"},{"issue":"1","key":"key\n\t\t\t\t20170521015742_CIT0049","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol"},{"issue":"5","key":"key\n\t\t\t\t20170521015742_CIT0050","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/hed.20859","article-title":"Emerging perspectives in epidermal growth factor receptor targeting in head and neck cancer","volume":"30","author":"Kim","year":"2008","journal-title":"Head Neck"},{"issue":"9","key":"key\n\t\t\t\t20170521015742_CIT0051","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrclinonc.2009.111","article-title":"Implications for KRAS status and EGFR-targeted therapies in metastatic CRC","volume":"6","author":"Normanno","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"key\n\t\t\t\t20170521015742_CIT0052","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1200\/JCO.2009.24.6116","article-title":"Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer","volume":"28","author":"Bardelli","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4","key":"key\n\t\t\t\t20170521015742_CIT0053","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1158\/1940-6207.CAPR-11-0502","article-title":"Metformin prevents the development of oral squamous cell carcinomas from carcinogen-induced premalignant lesions","volume":"5","author":"Vitale-Cross","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"issue":"5","key":"key\n\t\t\t\t20170521015742_CIT0054","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1158\/1940-6207.CAPR-09-0058","article-title":"Chemical carcinogenesis models for evaluating molecular-targeted prevention and treatment of oral cancer","volume":"2","author":"Vitale-Cross","year":"2009","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"key\n\t\t\t\t20170521015742_CIT0055","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1371\/journal.pmed.0050008","article-title":"Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma","volume":"5","author":"Cloughesy","year":"2008","journal-title":"PLoS Med"},{"issue":"1","key":"key\n\t\t\t\t20170521015742_CIT0056","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/blood-2007-03-080796","article-title":"Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase\/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways","volume":"111","author":"Tamburini","year":"2008","journal-title":"Blood"},{"issue":"14","key":"key\n\t\t\t\t20170521015742_CIT0057","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1158\/0008-5472.CAN-10-0157","article-title":"The epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1alpha and Bcl-2 and activating the beclin 1\/hVps34 complex","volume":"70","author":"Li","year":"2010","journal-title":"Cancer Res"},{"issue":"2","key":"key\n\t\t\t\t20170521015742_CIT0058","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat Cell Biol"},{"key":"key\n\t\t\t\t20170521015742_CIT0059","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/jamaoto.2013.3210","article-title":"High Frequency of Activating PIK3CA Mutations in Human Papillomavirus\u2013Positive Oropharyngeal Cancer","volume":"139","author":"Nichols","year":"2013","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"9","key":"key\n\t\t\t\t20170521015742_CIT0060","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1158\/1078-0432.CCR-13-2585","article-title":"Reverse Phase Protein Array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancer","volume":"20","author":"Sewell","year":"2014","journal-title":"Clin Cancer Res"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/106\/9\/dju215\/17313515\/dju215.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T00:00:32Z","timestamp":1598140832000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/dju215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,5]]},"references-count":60,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,8,5]]},"published-print":{"date-parts":[[2014,9]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/dju215","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8,5]]}}}